With the breast cancer awareness month approaching this October, now may be the perfect time to highlight the importance of early detection and treatment of the disease. The early symptoms of breast cancer are not exactly easy to spot, and many women tend to ignore the signs. Some may not even exhibit noticeable symptoms, so it’s better to undergo mammography exam if a woman suspects that something is not right.
But in some cases, the signs of breast cancer are easy to detect. The most common symptom is a lump. However, it should be noted that not all lumps are cancerous. Swelling of the breast and skin irritation is a sign as well. Other symptoms include pain in the breast or nipple and the thickening of the skin around that area. Nipple discharge is possible as well.
Women should go to the doctor immediately if they noticed those signs because early detection is vital to increase the chances of removing it before it becomes an advanced breast cancer.
As the Advanced Breast Cancer community explains: “Advanced breast cancer includes the most serious of the five possible stages, Stages 3 and 4. Stage 3 is locally advanced breast cancer, which means cancer has spread to lymph nodes and other tissue in the breast, but not to further sites in the body. Stage 4 is metastatic breast cancer. At this stage, cancer has spread to other sites of the body, such as the liver, lungs, bones, brain, and/or others.”
Breast cancer becomes life-threatening once it advances into stage 4 and spreads to other parts of the body. Once a woman enters stage 4, the survival rate drops drastically so don’t wait for that to happen. If you noticed something unusual with your breast, it might be time to head to the doctors to get it checked.


Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
France Keeps Top Health Alert as Officials Brace for Another Heatwave
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 



